Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive‐enhancing medications

Background: PD psychosis is often associated with cognitive impairment, including dementia, and involves dopaminergic, serotonergic, and cholinergic mechanisms. Objective: To evaluate the differential effect of the antipsychotic pimavanserin, a selective serotonin 2A receptor inverse agonist, in PD...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mov Disord
Hlavní autoři: Espay, Alberto J., Guskey, Michael T., Norton, James C., Coate, Bruce, Vizcarra, Joaquin A., Ballard, Clive, Factor, Stewart A., Friedman, Joseph H., Lang, Anthony E., Larsen, Niccole J., Andersson, Candace, Fredericks, Doral, Weintraub, Daniel
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6261678/
https://ncbi.nlm.nih.gov/pubmed/30387904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.27488
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky